AKT INHIBITION PROMOTES NON-AUTONOMOUS CANCER CELL SURVIVAL

Small-molecule inhibitors of AKT signaling are being evaluated in patients with various cancer types, but have so far proven therapeutically disappointing for reasons that remain unclear. Here, we treat cancer cells with sub-therapeutic doses of Akti-1/2, an allosteric small molecule AKT inhibitor,...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Cancer Ther
Main Authors: Salony, Solé, Xavier, Alves, Cleidson P., Dey-Guha, Ipsita, Ritsma, Laila, Boukhali, Myriam, Lee, Ju H., Chowdhury, Joeeta, Ross, Kenneth N., Haas, Wilhelm, Vasudevan, Shobha, Ramaswamy, Sridhar
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4707053/
https://ncbi.nlm.nih.gov/pubmed/26637368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-15-0414
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker